Correlation Between ABIVAX Société and VanEck UraniumNuclear

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ABIVAX Société and VanEck UraniumNuclear at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABIVAX Société and VanEck UraniumNuclear into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABIVAX Socit Anonyme and VanEck UraniumNuclear Energy, you can compare the effects of market volatilities on ABIVAX Société and VanEck UraniumNuclear and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABIVAX Société with a short position of VanEck UraniumNuclear. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABIVAX Société and VanEck UraniumNuclear.

Diversification Opportunities for ABIVAX Société and VanEck UraniumNuclear

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between ABIVAX and VanEck is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ABIVAX Socit Anonyme and VanEck UraniumNuclear Energy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VanEck UraniumNuclear and ABIVAX Société is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABIVAX Socit Anonyme are associated (or correlated) with VanEck UraniumNuclear. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VanEck UraniumNuclear has no effect on the direction of ABIVAX Société i.e., ABIVAX Société and VanEck UraniumNuclear go up and down completely randomly.

Pair Corralation between ABIVAX Société and VanEck UraniumNuclear

Assuming the 90 days horizon ABIVAX Socit Anonyme is expected to under-perform the VanEck UraniumNuclear. In addition to that, ABIVAX Société is 1.28 times more volatile than VanEck UraniumNuclear Energy. It trades about -0.09 of its total potential returns per unit of risk. VanEck UraniumNuclear Energy is currently generating about 0.06 per unit of volatility. If you would invest  8,531  in VanEck UraniumNuclear Energy on September 1, 2024 and sell it today you would earn a total of  1,006  from holding VanEck UraniumNuclear Energy or generate 11.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.21%
ValuesDaily Returns

ABIVAX Socit Anonyme  vs.  VanEck UraniumNuclear Energy

 Performance 
       Timeline  
ABIVAX Socit Anonyme 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABIVAX Socit Anonyme has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, ABIVAX Société is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
VanEck UraniumNuclear 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in VanEck UraniumNuclear Energy are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak essential indicators, VanEck UraniumNuclear reported solid returns over the last few months and may actually be approaching a breakup point.

ABIVAX Société and VanEck UraniumNuclear Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ABIVAX Société and VanEck UraniumNuclear

The main advantage of trading using opposite ABIVAX Société and VanEck UraniumNuclear positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABIVAX Société position performs unexpectedly, VanEck UraniumNuclear can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VanEck UraniumNuclear will offset losses from the drop in VanEck UraniumNuclear's long position.
The idea behind ABIVAX Socit Anonyme and VanEck UraniumNuclear Energy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance